Cargando…
Treatment of breast cancer stem cells with oncolytic herpes simplex virus
Cancer stem cells have recently been isolated from several different solid tumors. In breast cancer, the CD44(+)CD24(−/low) population is considered to comprise stem-like cells. The identification of cancer stem cells has provided new targets for the development of therapeutics. Oncolytic herpes sim...
Autores principales: | Li, J, Zeng, W, Huang, Y, Zhang, Q, Hu, P, Rabkin, S D, Liu, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444761/ https://www.ncbi.nlm.nih.gov/pubmed/22898897 http://dx.doi.org/10.1038/cgt.2012.49 |
Ejemplares similares
-
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
por: Kardani, Kimia, et al.
Publicado: (2023) -
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
por: Wang, Jiani, et al.
Publicado: (2014) -
Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018) -
Designing herpes viruses as oncolytics
por: Peters, Cole, et al.
Publicado: (2015) -
Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)